Precision healthcare could be Taiwan’s strength

Taiwan's push into precision healthcare, driven by AI and its robust semiconductor industry, represents a significant strategic pivot. The plan, articulated by Wong Chi-huey, focuses on integrating National Health Insurance data with genomic information to create a powerful AI learning platform. This move could position Taiwan as a leader in an aging global economy where medical spending is projected to reach US$15 trillion by 2030, up from US$10.6 trillion in 2018. The emphasis on developing biomedical chips and smart healthcare computing leverages existing national strengths, creating a clear path for growth. The real challenge for Taiwan will be the execution of its four priorities: data integration, technological development, talent cultivation, and international cooperation. While the government's commitment, including a NT$10 billion investment program and the Ten AI Initiatives Promotion Plan, is substantial, the success hinges on effective implementation and overcoming potential data privacy concerns. The goal is to build a "smart biotech national team" that combines Taiwan's hardware prowess with its healthcare sector, but the global competition for AI and biotech talent remains fierce. For Asia, this initiative could establish a new benchmark for national healthcare innovation, particularly in how AI and big data are applied to public health systems. The focus on prevention and precision health could yield models applicable across other aging Asian economies. However, the window for Taiwan to solidify its position in advanced robotics supply chains, particularly outside China, is described as a "golden but narrowing" three-to-five-year period, suggesting urgency in these efforts.